Accelerated rTMS vs. Sham for Stroke Apathy
NCT: NCT07113067 · RECRUITING
Brief Summary
Apathy is a common set of symptoms seen in many people following a stroke. Apathy occurs when a person has lost motivation, becomes withdrawn, and stops doing things that used to be important to them. Apathy has a large negative impact on a person's quality of life, and can also have a large impact the people who take care of them. There are currently no FDA-approved treatments to help with apathy, and other services like therapy may be difficult to access for people who have had a stroke. To address this problem, investigators are conducting a study to find out if a form of treatment called repetitive transcranial magnetic stimulation (rTMS) can be safe and helpful for people struggling with apathy after a stroke. This study will apply a new form of rTMS which can be delivered quickly to a part of the brain called the medial prefrontal cortex (mPFC). This study will help establish whether this treatment is safe, comfortable, and effective for people with apathy after a stroke, and will help researchers develop new forms of treatment.
Frequently Asked Questions
What is Accelerated rTMS vs. Sham for Stroke Apathy?
Accelerated rTMS vs. Sham for Stroke Apathy is a clinical trial registered under NCT07113067. Current status: RECRUITING.
What is the status of NCT07113067?
The current status of NCT07113067 (Accelerated rTMS vs. Sham for Stroke Apathy) is: RECRUITING.
When did Accelerated rTMS vs. Sham for Stroke Apathy start?
Accelerated rTMS vs. Sham for Stroke Apathy started on 2025-08-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.